All News

Found 6,418 articles

• Amphastar Receives FDA Approval for Vasopressin

  7/19/2022

  Amphastar Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved the Company's Abbreviated New Drug Application for Vasopressin injection, USP 20 Units/mL, 1mL Single Dose Vial.

• Insulin Market Size to Worth Around USD 23.57 Billion by 2030

  7/19/2022

  The global insulin market size is expected to be worth around USD 23.57 billion by 2030 from valued at USD 20.55 billion in 2021 and anticipated to grow at a CAGR of 1.54% during the forecast period 2022 to 2030.

• Significant Glycemic Control and Weight Loss: Innovent Announces Phase 2 Study of Mazdutide (IBI362) in Chinese Patients with Type 2 Diabetes Met Primary Endpoint

  7/18/2022

  Innovent Biologics, Inc. (Innovent) (HKEX: 01801), announces that the primary endpoint was met in a multi-center, randomized, double-blind, placebo and dulaglutide-controlled phase 2 study of mazdutide (R&D code: IBI362), a glucagon-like peptide-1 receptor (GLP-1R) and glucagon receptor (GCGR) dual agonist, in Chinese patients with type 2 diabetes.

• Healthcare Analytical Testing Services Market: Increasing Analytical Testing Rate of Biosimilar and Biologics to Drive the Market

  7/18/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: The global healthcare analytical testing services market has gathered pace in its growth due to the enormous demand for research and development outsourcing.

• Coagulation Analysers Market: Rising Incidence of Cardiovascular Diseases to Drive the Market

  7/15/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: The global coagulation analysers market is treading along a lucrative trajectory in recent times.

• Magnetic Resonance Imaging Market Growth By 2030: Increase In Demand For Neurological Procedures

  7/15/2022

  The global magnetic resonance imaging market is forecast to reach USD 10.33 Billion by 2030, according to a new report by Reports and Data.

• Alvotech Expands its Board of Directors as part of Transition from Private to Publicly Traded Company

  7/14/2022

  Alvotech, a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced the expansion of its board of directors as part of its transition from a private to a publicly traded company.

• Covis Pharma Group Announces Executive Leadership Appointment in Canada

  7/14/2022

  Covis Pharma Group announced the appointment of Christine Poulin as Senior Vice President & General Manager, Canada, effective August 8, 2022.

• Aurinia Announces the Addition of Three Seasoned Executive Leaders to Advance Company Strategy and Performance

  7/14/2022

  Aurinia Pharmaceuticals Inc., a biopharmaceutical company committed to delivering therapeutics that change the course of autoimmune disease, announced the appointment of three seasoned leaders to the Aurinia executive team.

• Avastin to Remain Leader in the Colorectal Cancer Drugs Market | GlobalData PlcRoche’s anti-angiogenesis drug Avastin (bevacizumab) has held a dominant position in the CRC market for many years

  7/14/2022

  The “Colorectal Cancer – Global Drug Forecast and Market Analysis to 2028” market research report offered by GlobalData provides an overview of metastatic colorectal cancer including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.

• Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update

  7/14/2022

  Theratechnologies Inc. today reported business highlights and financial results for the second quarter and first half of fiscal year 2022 ended May 31, 2022. All figures are in U.S. dollars unless otherwise stated.

• Insulin Market: Increase in Incidence of Diabetes Globally to Drive Market Demand

  7/14/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: Insulin is a hormone produced by human pancreas that controls the amount of glucose levels in the bloodstream, and regulates human body’s metabolism of fats, proteins, and carbohydrates.

• Telemedicine Market Growth by 2030: High Demand for Virtual Medical Consultations and Rapid Technological Advancements

  7/14/2022

  According to a new report by Reports and Data, the global Telemedicine market is forecast to reach USD 565.81 billion by 2030.

• Biopharmaceuticals Contract Manufacturing Market Size USD 27.5 Billion by 2030

  7/14/2022

  According to Latest Study, the global biopharmaceuticals contract manufacturing market was surpassed at USD 17.1 billion in 2021 and is expected to hit around USD 27.5 billion by 2030, growing at a CAGR of 5.42% from 2022 to 2030.

• Bio-Thera Solutions Announces First Patient Dosed in Phase 1 Study for BAT8006, an Antibody Drug Conjugate Targeting Folate Receptor α for the Treatment of Advanced Solid Tumors

  7/13/2022

  Bio-Thera Solutions, Ltd. (SH: 688177), a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase 1 clinical study evaluating BAT8006, an antibody drug conjugate (ADC) that targets folic acid receptor α (FRα).

• Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management

  7/13/2022

  Financing Will Significantly Strengthen the Balance Sheet and Extend Cash Runway.

• Opioid Pain Therapeutics Market: Technological Advancement and New Product Lunch to Drive the Market

  7/13/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: Potent pain reducing medications made with compounds such as morphine, hydrocodone, codeine, methadone, and oxycodone fall under the category of opioid drugs.

• Biopharmaceutical CMO & CRO Market In-Depth Analysis & Forecast 2019-2027

  7/13/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc.: Huge investments made in biopharmaceutical industry by the key players with the aim to improve their productivity and efficiency.

• 

  Movers & Shakers: Adagio, Harpoon, Aravive, Nitrase and More

  7/8/2022

  Adagio, Aravive, PolyPid, Harpoon, Durect, Nitrase, Kallyope, TScan and many more made major leadership decisions this week.

• Dr. Reddy's Laboratories Announces the Launch of Fesoterodine Fumarate Extended-Release Tablets in the U.S. Market

  7/8/2022

  Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) announces the launch of Dr. Reddy’s Fesoterodine Fumarate Extended-Release Tablets, a therapeutic generic equivalent to Toviaz® (fesoterodine fumarate) Extended-Release Tablets in the U.S. market following the approval by the U.S. Food and Drug Administration (USFDA).